Accurate quantitation of choline and ethanolamine plasmalogen molecular species in human plasma by liquid chromatography–tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 134, Issue , 2017, Pages 77-85

  Otoki, Yurika ^a   Kato, Shunji ^a   Kimura, Fumiko ^a   Furukawa, Katsutoshi ^a   Yamashita, Shinji ^b   Arai, Hiroyuki ^a   Miyazawa, Teruo ^a   Nakagawa, Kiyotaka ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Human plasma; Mass spectrometry; Phospholipid; Plasmalogen; Sodium adduct

Indexed keywords

CHOLINE; ETHANOLAMINE; METHANOL; PLASMALOGEN; SODIUM; CHOLINE PLASMALOGENS; PHOSPHATIDAL ETHANOLAMINES;

ACCURACY; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION STUDY; EXTRACTION; FEMALE; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPH; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; MASS SPECTROMETER; MULTIPLE REACTION MONITORING; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ANIMAL; BLOOD; LIQUID CHROMATOGRAPHY; PROCEDURES; RAT; STANDARDS; TANDEM MASS SPECTROMETRY;

ALZHEIMER DISEASE; ANIMALS; CHROMATOGRAPHY, LIQUID; HUMANS; PLASMALOGENS; RATS; TANDEM MASS SPECTROMETRY;

EID: 84999053645     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2016.11.019     Document Type: Article

References (30)

1. [1] Brites, P., Waterham, H.R., Wanders, R.J., Functions and biosynthesis of plasmalogens in health and disease. Biochim. Biophys. Acta 1636 (2004), 219–231.
2. [2] Braverman, N.E., Moser, A.B., Functions of plasmalogen lipids in health and disease. Biochim. Biophys. Acta 1822 (2012), 1442–1452.
3. [3] Brautigam, C., Engelmann, B., Reiss, D., Reinhardt, U., Richter, W.O., Brosche, T., Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis. Atherosclerosis 119 (1996), 77–88.
4. [4] Goodenowe, D.B., Cook, L.L., Liu, J., Lu, Y., Jayasinghe, D.A., Ahiahonu, P.W., Heath, D., Yamazaki, Y., Flax, J., Krenitsky, K.F., Sparks, D.L., Lerner, A., Friedland, R.P., Kudo, T., Kamino, K., Morihara, T., Takeda, M., Wood, P.L., Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia. J. Lipid Res. 48 (2007), 2485–2489.
5. [5] Wood, P.L., Mankidy, R., Ritchie, S., Heath, D., Wood, J.A., Flax, J., Goodenowe, D.B., Circulating plasmalogen levels and Alzheimer disease assessment scale-cognitive scores in Alzheimer patients. J. Phychiatry Neurosci. 35 (2010), 59–62.
6. [6] Yamashita, S., Kiko, T., Fujiwara, H., Hashimoto, M., Nakagawa, K., Kinoshita, M., Furukawa, K., Arai, H., Miyazawa, T., Alterations in the levels of amyloid-beta, phospholipid hydroperoxide, and plasmalogen in the blood of patients with Alzheimer's disease: possible interactions between amyloid-beta and these lipids. J. Alzheimers Dis. 50 (2015), 527–537.
7. [7] Oma, S., Mawatari, S., Saito, K., Wakana, C., Tsuboi, Y., Yamada, T., Fujino, T., Changes in phospholipid composition of erythrocyte membrane in Alzheimer's disease. Dement. Geriatr. Cogn. Dis. Extra 2 (2012), 298–303.
8. [8] Nishimukai, M., Maeba, R., Yamazaki, Y., Nezu, T., Sakurai, T., Takahashi, Y., Hui, S.P., Chiba, H., Okazaki, T., Hara, H., Serum choline plasmalogens particularly those with oleic acid in sn-2, are associated with proatherogenic state. J. Lipid Res. 55 (2014), 956–965.
9. [9] Nishimukai, M., Maeba, R., Ikuta, A., Asakawa, N., Kamiya, K., Yamada, S., Yokota, T., Sakakibara, M., Tsutsui, H., Sakurai, T., Takahashi, Y., Hui, S.P., Chiba, H., Okazaki, T., Hara, H., Serum choline plasmalogens-those with oleinic acid in sn-2 are biomarkers for coronary artery disease. Clin. Chim. Acta 437 (2014), 147–154.
10. [10] Sutter, I., Klingenberg, R., Othman, A., Rohrer, L., Landmesser, U., Heg, D., Rodondi, N., Mach, F., Windecker, S., Matter, C.M., Luscher, T.F., von Eckardstein, A., Hornemann, T., Decreased phosphatidylcholine plasmalogens – a putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction. Atherosclerosis 246 (2016), 130–140.
11. [11] Zemski, B.K.A., Murphy, R.C., Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids. J. Am. Soc. Mass Spectrom. 15 (2004), 1499–1508.
12. [12] Hsu, F.F., Turk, J., Thukkani, A.K., Messner, M.C., Wildsmith, K.R., Ford, D.A., Characterization of alkylacyl, alk-1-enylacyl and lyso subclasses of glycerophosphocholine by tandem quadrupole mass spectrometry with electrospray ionization. J. Mass Spectrom. 38 (2003), 752–763.
13. [13] Otoki, Y., Nakagawa, K., Kato, S., Miyazawa, T., MS/MS and LC–MS/MS analysis of choline/ethanolamine plasmalogens via promotion of alkali metal adduct formation. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1004 (2015), 85–92.
14. [14] Wiesner, P., Leidl, K., Boettcher, A., Schmiz, G., Liebisch, G., Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J. Lipid Res. 50 (2009), 574–585.
15. [15] Zoeller, R.A., Morand, O.H., Raetz, C.R., A possible role for plasmalogens in protecting animal cells against photosensitized killing. J. Biol. Chem. 263 (1988), 11590–11596.
16. [16] Reiss, D., Beyer, K., Engelmann, B., Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. J. Biochem. 323 (1997), 807–814.
17. [17] Han, X., Gross, R.W., Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 6 (1995), 1202–1210.
18. [18] Yang, K., Zhao, Z., Gross, R.W., Han, X., Systematic analysis of choline-containing phospholipids using multi-dimensional mass spectrometry-based shotgun lipidomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 (2009), 2924–2936.
19. [19] Hsu, F.F., Turk, J., Characterization of phosphatidylethanolamine as a lithiated adduct by triple quadrupole tandem mass spectrometry with electrospray ionization. J. Mass Spectrom. 35 (2000), 596–606.
20. [20] Donato, P., Cacciola, F., Tranchida, P.Q., Dugo, P., Mondello, L., Mass spectrometry detection in comprehensive liquid chromatography: basic concepts, instrumental aspects, applications and trends. Mass Spectrom. Rev. 31 (2012), 523–559.
21. [21] Kato, S., Nakagawa, K., Suzuki, Y., Asai, A., Nagao, M., Nagashima, K., Oikawa, S., Miyazawa, T., Liquid chromatography–tandem mass spectrometry determination of human plasma 1-palmitoyl-2-hydroperoxyoctadecadienoyl-phosphatidylcholine isomers via promotion of sodium adduct formation. Anal. Biochem. 471 (2014), 51–60.
22. [22] Folch, J., Lees, M., Sloane-Stanley, G.H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957), 497–509.
23. [23] Bligh, E.G., Dyer, W.J., A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959), 911–917.
24. [24] Maeba, R., Nishimukai, M., Sakasegawa, S., Sugimori, D., Hara, H., Plasma/serum plasmalogens: methods of analysis and clinical significance. Adv. Clin. Chem. 70 (2015), 31–94.
25. [25] Sindelar, P.J., Guan, Z., Dallner, G., Ernster, L., The protective role of plasmalogens in ion-induced lipid peroxidation. Free Radic. Biol. Med. 26 (1999), 318–324.
26. [26] Hui, S.P., Chiba, H., Kurosawa, T., Liquid chromatography–mass spectrometric determination of plasmalogens in human plasma. Anal. Bioanal. Chem. 400 (2011), 1923–1931.
27. [27] Want, E.J., O'Maille, G., Smith, C.A., Brandon, T.R., Uritboonthai, W., Qin, C., Trauger, S.A., Siuzdak, G., Solvent-dependent metabolite distribution clustering, and protein extraction for serum profiling with mass spectrometry. Anal. Chem. 78 (2006), 743–752.
28. [28] Igarashi, M., Ma, K., Gao, F., Kim, H.W., Rapoport, S.I., Rao, J.S., Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. J. Alzheimer Dis. 24 (2011), 507–517.
29. [29] Ginsberg, L., Rafique, S., Xuereb, J.H., Rapoport, S.I., Gershfeld, N.L., Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res. 698 (1995), 223–226.
30. [30] Han, X., Holtzman, D.M., McKeel, D.W. Jr., Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77 (2001), 1168–1180.